A Newly Published Network Meta-Analysis (NMA) Found TREMFYA ® (guselkumab) Ranked Highest for Overall Level of Skin Clearance and Provided Positive Joint Efficacy Among Active Psoriatic Arthritis (PsA) Therapies
Conclusions (i.e., comparable) are based on an overlap of pairwise 95 percent credible intervals.1c. PASI 90 is defined as at least 90 percent improvement from baseline in the PASI score. The PASI score grades the amount of surface area on each body region that is covered by PsO plaques and the severity of plaques for their redness, thickness, and scaliness.13 PASI 90 was not a controlled endpoint in DISCOVER-1 or -2.8,9d. TREMFYA q4w dosing is not currently FDA-approved.2e. The PsA-modified vdH-S score combines erosion and joint space narrowing scores derived from radiographs of joints in body regions impacted by PsA.14 T...
Source: Johnson and Johnson - January 26, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Anthem Profits Double To $1 Billion On Pandemic Medicaid Growth
Anthem ’s fourth quarter profits doubled to $1.1 billion thanks to strong enrollment in its Medicaid plans that have drawn more people to such coverage during the Covid-19 pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 26, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Decision Maker Content decisionmaker business pharma Source Type: news

Johnson & Johnson Reports Q4 and Full-Year 2021 Results
New Brunswick, N.J. (January 25, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. “Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers” said Joaquin Duato, Chief Executive Officer. “Given our strong results, financial profile, and innovative pipeline we are well positioned for success in 2022 and beyond.” OVERALL FINANCIAL RESULTS ...
Source: Johnson and Johnson - January 25, 2022 Category: Pharmaceuticals Tags: Financial Source Type: news

The Lancet publishes studies showing Roche ’s faricimab improved and maintained vision in two leading causes of vision loss, extending time between treatments up to four months
Basel, 24 January 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that The Lancet has published two papers highlighting one-year results from four pivotal phase III studies of faricimab, an investigational bispecific antibody, in neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). [1,2] All four studies – which enrolled more than 3,000 people in total – met their primary endpoints, showing that people treated with faricimab up to every four months achieved non-inferior vision gains compare d to aflibercept given every two months. Notably, about half of eligible f...
Source: Roche Media News - January 24, 2022 Category: Pharmaceuticals Source Type: news

The Lancet publishes studies showing Roche ’s faricimab improved and maintained vision in two leading causes of vision loss, extending time between treatments up to four months
Basel, 24 January 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that The Lancet has published two papers highlighting one-year results from four pivotal phase III studies of faricimab, an investigational bispecific antibody, in neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). [1,2] All four studies – which enrolled more than 3,000 people in total – met their primary endpoints, showing that people treated with faricimab up to every four months achieved non-inferior vision gains compare d to aflibercept given every two months. Notably, about half of eligible f...
Source: Roche Investor Update - January 24, 2022 Category: Pharmaceuticals Source Type: news

Biocon Biologics set to reap biosimilar insulin glargine opportunity in US
Drugmaker Biocon is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and profit growth in the next several quarters, primarily from the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 22, 2022 Category: Pharmaceuticals Source Type: news

Lakers' Russell Westbrook 'Disappointed' in 4th-Quarter Benching vs. Pacers
Los Angeles Lakers point guard Russell Westbrook said he felt "disappointed" after getting benched for the final four minutes of Wednesday's 111-104 home loss... #russellwestbrook #pacers #pointguard #losangeleslakers #homeloss (Source: Reuters: Health)
Source: Reuters: Health - January 21, 2022 Category: Consumer Health News Source Type: news

Russell Westbrook disappointed with benching, remains undeterred about helping Los Angeles Lakers win in long run
Lakers star Russell Westbrook told ESPN that he was disappointed with his fourth-quarter benching in Wednesday's loss to the Pacers but that he remains undeterred about figuring out how to help... #pacers #losangeleslakers #russellwestbrook (Source: Reuters: Health)
Source: Reuters: Health - January 21, 2022 Category: Consumer Health News Source Type: news

UnitedHealth ’s Medicare Growth Helps Weather Ongoing Pandemic
UnitedHealth Group ’s profits eclipsed $4 billion in the fourth quarter of last year thanks to a strong performance in the company’s health insurance business led by Medicare growth. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 19, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech business pharma Source Type: news

UnitedHealth Group ’s Profits Eclipse $4 Billion As Medicare Growth Helps Overcome Pandemic
UnitedHealth Group ’s profits eclipsed $4 billion in the fourth quarter thanks to a strong performance in the company’s health insurance business led by Medicare growth. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 19, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Coronavirus Decision Maker Content decisionmaker business pharma Source Type: news

Dak Prescott apologizes after drawing criticism for postgame comments after Cowboys' wild-card playoff loss
Dallas Cowboys quarterback Dak Prescott issued an apology Tuesday for comments made in the wake of his team's wild-card playoff loss. #dakprescott #playoffloss #quarterback #dallascowboys (Source: Reuters: Health)
Source: Reuters: Health - January 19, 2022 Category: Consumer Health News Source Type: news

Live news from December 18: Microsoft to buy video game maker Activision Blizzard for $75bn, Bank of Japan raises inflation projection amid ‘evident’ pick-up, Goldman’s quarterly profit drops as trading revenue declines
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 18, 2022 Category: Pharmaceuticals Source Type: news

Cowboys' Dak Prescott, Mike McCarthy explain final play, coach says he was told time would be back on clock
Dallas Cowboys coach Mike McCarthy and quarterback Dak Prescott tried to explain what happened in the waning moments of their loss to the San Francisco 49ers in the NFC wild-card playoff round Sunday. #dallascowboys #dakprescott #nfc #mikemccarthy #playoffround #sanfrancisco49ers (Source: Reuters: Health)
Source: Reuters: Health - January 17, 2022 Category: Consumer Health News Source Type: news

Steelers' Ben Roethlisberger reflects on legacy after playoff loss: 'It has just truly been a blessing'
The Pittsburgh Steelers suffered a 42-21 blowout from the Kansas City Chiefs Sunday but quarterback Ben Roethlisberger still feels “blessed” to have played in what will likely be his last NFL game. #benroethlisberger #playoffloss #blowout #kansascitychiefs #pittsburghsteelers (Source: Reuters: Health)
Source: Reuters: Health - January 17, 2022 Category: Consumer Health News Source Type: news

Eagles vs. Buccaneers snap count analysis: DeVonta Smith criminally underutilized
Time to analyze the Philadelphia Eagles’ snap counts from their wild card loss to the Tampa Bay Buccaneers. Tough to have most of the offensive line and the starting quarterback play... #philadelphiaeagles #tampabaybuccaneers #quarterback #devontasmith (Source: Reuters: Health)
Source: Reuters: Health - January 17, 2022 Category: Consumer Health News Source Type: news